![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
The potential for less
PN dependence
People with SBS who
were treated with
Zorbtive—a study summary
What some people
experienced after treatment
 |
| “The freedom to get up and go. That’s what I want.” |
Zorbtive® [somatropin (rDNA origin) for injection] was given to people with SBS in a study conducted by doctors and dietitians experienced with Short Bowel Syndrome.
| About the study... |
| Forty-one people were treated |
| Their average length of remaining small intestine was 2.4 feet |
| They had been using parenteral nutrition (PN) for several years |
| They received PN between five and six days per week |
| All people in the study were placed on a special high-carb, low-fat diet at least two weeks before Zorbtive treatment |
Each person was assigned to one of the treatment groups below and
received 28 days of treatment. (Note: Treatment for more than 28 days has not been adequately studied.)
| Treatment groups... |
| Group One: people treated with glutamine* by itself |
| Group Two: people treated with Zorbtive by itself |
| Group Three: people treated with both Zorbtive and glutamine |
* Glutamine is an amino acid your body naturally produces.
The potential for less PN dependence
People with SBS who were treated with Zorbtive—a study summary
What some people experienced after treatment
Frequently asked questions
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients
and interested healthcare professionals about this treatment for Short Bowel Syndrome.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 